{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:56:13Z","timestamp":1768078573326,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-024-02982-0","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T17:01:51Z","timestamp":1727542911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Noriyuki","family":"Enomoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Mochizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuki","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyogo","family":"Naoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Karayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Imokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Koshimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Yokomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Sumikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"2982_CR1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.chest.2016.11.003","volume":"151","author":"KC Patterson","year":"2017","unstructured":"Patterson KC, Shah RJ, Porteous MK, Christie JD, D\u2019Errico CA, Chadwick M, Triano MJ, Deshpande C, Rossman MD, Litzky LA, et al. Interstitial lung disease in the Elderly. Chest. 2017;151:838\u201344.","journal-title":"Chest"},{"key":"2982_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1378\/chest.130.1.22","volume":"130","author":"N Enomoto","year":"2006","unstructured":"Enomoto N, Suda T, Kato M, Kaida Y, Nakamura Y, Imokawa S, Ida M, Chida K. Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest. 2006;130:22\u20139.","journal-title":"Chest"},{"key":"2982_CR3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1183\/13993003.01565-2015","volume":"47","author":"JM Oldham","year":"2016","unstructured":"Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, Husain AN, Montner S, Chung JH, Cottin V, et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J. 2016;47:1767\u201375.","journal-title":"Eur Respir J"},{"key":"2982_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1164\/rccm.202201-0124OC","volume":"207","author":"JV Pugashetti","year":"2023","unstructured":"Pugashetti JV, Adegunsoye A, Wu Z, Lee CT, Srikrishnan A, Ghodrati S, Vo V, Renzoni EA, Wells AU, Garcia CK, et al. Validation of proposed Criteria for Progressive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023;207:69\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"2982_CR5","doi-asserted-by":"crossref","unstructured":"Hambly N, Farooqi MM, Dvorkin-Gheva A, Donohoe K, Garlick K, Scallan C, Chong SG, MacIsaac S, Assayag D, Johannson KA et al. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry. Eur Respir J 2022, 60.","DOI":"10.1183\/13993003.02571-2021"},{"key":"2982_CR6","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","volume":"366","author":"G Raghu","year":"2012","unstructured":"Idiopathic Pulmonary Fibrosis Clinical Research N, Raghu G, Anstrom KJ, King TE Jr., Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366:1968\u201377.","journal-title":"N Engl J Med"},{"key":"2982_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083\u201392.","journal-title":"N Engl J Med"},{"key":"2982_CR8","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071\u201382.","journal-title":"N Engl J Med"},{"key":"2982_CR9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, et al. An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46:976\u201387.","journal-title":"Eur Respir J"},{"key":"2982_CR10","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.rmed.2015.08.010","volume":"109","author":"D Assayag","year":"2015","unstructured":"Assayag D, Kim EJ, Elicker BM, Jones KD, Golden JA, King TE Jr., Koth LL, Shum AK, Wolters PJ, Collard HR, Lee JS. Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria. Respir Med. 2015;109:1326\u201331.","journal-title":"Respir Med"},{"key":"2982_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/thoraxjnl-2020-216263","volume":"77","author":"N Enomoto","year":"2022","unstructured":"Enomoto N, Homma S, Inase N, Kondoh Y, Saraya T, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, et al. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias. Thorax. 2022;77:143\u201353.","journal-title":"Thorax"},{"key":"2982_CR12","doi-asserted-by":"publisher","first-page":"107577","DOI":"10.1016\/j.rmed.2024.107577","volume":"224","author":"N Enomoto","year":"2024","unstructured":"Enomoto N, Yazawa S, Mochizuka Y, Fukada A, Tanaka Y, Naoi H, Aono Y, Inoue Y, Yasui H, Karayama M, et al. Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: a prospective, multicentre cohort study. Respir Med. 2024;224:107577.","journal-title":"Respir Med"},{"key":"2982_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.rmed.2016.09.002","volume":"119","author":"S Chartrand","year":"2016","unstructured":"Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A. Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience. Respir Med. 2016;119:150\u20134.","journal-title":"Respir Med"},{"key":"2982_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.rmed.2016.10.017","volume":"123","author":"K Ahmad","year":"2017","unstructured":"Ahmad K, Barba T, Gamondes D, Ginoux M, Khouatra C, Spagnolo P, Strek M, Thivolet-Bejui F, Traclet J, Cottin V. Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med. 2017;123:56\u201362.","journal-title":"Respir Med"},{"key":"2982_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.rmed.2018.02.024","volume":"137","author":"K Yoshimura","year":"2018","unstructured":"Yoshimura K, Kono M, Enomoto Y, Nishimoto K, Oyama Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, et al. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia. Respir Med. 2018;137:167\u201375.","journal-title":"Respir Med"},{"key":"2982_CR16","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s10067-018-4111-5","volume":"37","author":"J Dai","year":"2018","unstructured":"Dai J, Wang L, Yan X, Li H, Zhou K, He J, Meng F, Xu S, Liang G, Cai H. Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population-based study. Clin Rheumatol. 2018;37:2125\u201332.","journal-title":"Clin Rheumatol"},{"key":"2982_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/resp.13254","volume":"23","author":"BT Kelly","year":"2018","unstructured":"Kelly BT, Moua T. Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality. Respirology. 2018;23:600\u20135.","journal-title":"Respirology"},{"key":"2982_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1513\/AnnalsATS.201808-565CME","volume":"16","author":"BA Graney","year":"2019","unstructured":"Graney BA, Fischer A. Interstitial pneumonia with autoimmune features. Ann Am Thorac Soc. 2019;16:525\u201333.","journal-title":"Ann Am Thorac Soc"},{"key":"2982_CR19","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1002\/art.10577","volume":"46","author":"N Ogawa","year":"2002","unstructured":"Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren\u2019s syndrome. Arthritis Rheum. 2002;46:2730\u201341.","journal-title":"Arthritis Rheum"},{"key":"2982_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","volume":"47","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, Manfredi A, Frascerra S, Franzoni F, Galetta F, Ferrannini E. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis\u2013a longitudinal study. Rheumatology (Oxford). 2008;47:45\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"2982_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13:272\u201380.","journal-title":"Autoimmun Rev"},{"key":"2982_CR22","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/rheumatology\/kead409","volume":"63","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Ma X, Bai J, Xia S, Han Q, Luo Q. Characterizing the lavage and serum cytokine profiles of interstitial pneumonia with autoimmune features and their implications for progressive fibrosis. Rheumatology (Oxford). 2024;63:1230\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"2982_CR23","doi-asserted-by":"publisher","first-page":"38949","DOI":"10.1038\/srep38949","volume":"6","author":"M Liang","year":"2016","unstructured":"Liang M, Jiang Z, Huang Q, Liu L, Xue Y, Zhu X, Yu Y, Wan W, Yang H, Zou H. Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with interstitial pneumonia with autoimmune features (IPAF). Sci Rep. 2016;6:38949.","journal-title":"Sci Rep"},{"key":"2982_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12890-015-0105-0","volume":"15","author":"T Hamada","year":"2015","unstructured":"Hamada T, Samukawa T, Kumamoto T, Hatanaka K, Tsukuya G, Yamamoto M, Machida K, Watanabe M, Mizuno K, Higashimoto I, et al. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease. BMC Pulm Med. 2015;15:110.","journal-title":"BMC Pulm Med"},{"key":"2982_CR25","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1056\/NEJMoa1610528","volume":"376","author":"M Steri","year":"2017","unstructured":"Steri M, Orru V, Idda ML, Pitzalis M, Pala M, Zara I, Sidore C, Faa V, Floris M, Deiana M, et al. Overexpression of the Cytokine BAFF and Autoimmunity Risk. N Engl J Med. 2017;376:1615\u201326.","journal-title":"N Engl J Med"},{"key":"2982_CR26","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3109\/s10165-012-0755-1","volume":"23","author":"T Takahashi","year":"2013","unstructured":"Takahashi T, Asano Y, Akamata K, Aozasa N, Taniguchi T, Noda S, Masui Y, Ichimura Y, Toyama T, Tamaki Z, et al. Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis. Mod Rheumatol. 2013;23:884\u201390.","journal-title":"Mod Rheumatol"},{"key":"2982_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cyto.2016.10.011","volume":"98","author":"A La Cava","year":"2017","unstructured":"La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017;98:51\u20138.","journal-title":"Cytokine"},{"key":"2982_CR28","doi-asserted-by":"publisher","first-page":"15932","DOI":"10.1038\/s41598-020-73068-2","volume":"10","author":"K Chihara","year":"2020","unstructured":"Chihara K, Hattori N, Ichikawa N, Matsuda T, Saito T. Re-evaluation of serum leptin and adiponectin concentrations normalized by body fat mass in patients with rheumatoid arthritis. Sci Rep. 2020;10:15932.","journal-title":"Sci Rep"},{"key":"2982_CR29","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s00262-023-03453-z","volume":"72","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Inui N, Karayama M, Asada K, Fujii M, Matsuura S, Uto T, Hashimoto D, Matsui T, Ikeda M, et al. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1\/PD-L1 blockade therapy. Cancer Immunol Immunother. 2023;72:2717\u201328.","journal-title":"Cancer Immunol Immunother"},{"key":"2982_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2982_CR31","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205:e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"2982_CR32","doi-asserted-by":"crossref","unstructured":"Graham J, Ventura IB, Newton CA, Lee C, Boctor N, Pugashetti JV, Cutting C, Joerns E, Sandhu H, Chung JH et al. Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype. Eur Respir J 2020, 56.","DOI":"10.1183\/13993003.01205-2020"},{"key":"2982_CR33","doi-asserted-by":"publisher","first-page":"e0241719","DOI":"10.1371\/journal.pone.0241719","volume":"15","author":"M Kameda","year":"2020","unstructured":"Kameda M, Otsuka M, Chiba H, Kuronuma K, Hasegawa T, Takahashi H, Takahashi H. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features. PLoS ONE. 2020;15:e0241719.","journal-title":"PLoS ONE"},{"key":"2982_CR34","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/art.34330","volume":"64","author":"M Yellin","year":"2012","unstructured":"Yellin M, Paliienko I, Balanescu A, Ter-Vartanian S, Tseluyko V, Xu LA, Tao X, Cardarelli PM, Leblanc H, Nichol G, et al. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2012;64:1730\u20139.","journal-title":"Arthritis Rheum"},{"key":"2982_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/art.38904","volume":"67","author":"J Chen","year":"2015","unstructured":"Chen J, Doyle TJ, Liu Y, Aggarwal R, Wang X, Shi Y, Ge SX, Huang H, Lin Q, Liu W, et al. Biomarkers of rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 2015;67:28\u201338.","journal-title":"Arthritis Rheumatol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02982-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T17:04:03Z","timestamp":1727543043000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02982-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2982"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02982-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Hamamatsu University School of Medicine (approval number: E14-123) and registered in the University Hospital Medical Information Network (UMIN) system (, ID: UMIN000015370). This study was performed in accordance with the approved protocol and the 1964 Helsinki Declaration as amended.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NE received grants from Boehringer Ingelheim Co., Ltd. Other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}